Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa

The inadequate eradication of pulmonary infections and chronic inflammation are significant complications in cystic fibrosis (CF) patients, who usually suffer from persistent and frequent lung infections caused by several pathogens, particularly Pseudomonas aeruginosa (P. aeruginosa). The ability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Nouf M., Booq, Rayan Y., Aldossary, Ahmad M., Bakr, Abrar A., Almughem, Fahad A., Alfahad, Ahmed J., Alsharif, Wijdan K., Jarallah, Somayah J., Alharbi, Waleed S., Alsudir, Samar A., Alyamani, Essam J., Tawfik, Essam A., Alshehri, Abdullah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144307/
https://www.ncbi.nlm.nih.gov/pubmed/35631547
http://dx.doi.org/10.3390/pharmaceutics14050960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144307/
https://www.ncbi.nlm.nih.gov/pubmed/35631547
http://dx.doi.org/10.3390/pharmaceutics14050960

Ejemplares similares